Portable inhaler could revolutionise CF treatment

A HANDHELD inhaler could revolutionise how cystic fibrosis (CF) patients take life-saving antibiotics.

Portable inhaler could revolutionise CF treatment

Ireland has the highest incidence of CF in the world. One in 19 people carry the altered gene responsible for the disease.

The TOBI Podhaler will replace the need for those with CF to spend over 20 minutes, twice a day, at home hooked up to a mains-powered nebuliser.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited